Document is current
Any future updates will be listed below
-
Authors
Yu, Yilin
Wu, Haixia
Hong, Liang
Qiu, Jianjian
Wu, Shiji
Shao, Lingdong
Lin, Cheng
Wang, Zhiping
Wu, Junxin
-
Funding
Funding for this research was provided by:
the National Clinical Key Specialty Construction Program (2021, 2021)
the Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012, 2020Y2012)
Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies (2021Y2014, 2021Y2014)
- License Information
-
More Information
Article History
Received: 7 March 2024
Accepted: 5 September 2024
First Online: 11 September 2024
Declarations
:
: The current study was approved by the ethics committee of Fujian Medical University Cancer Hospital, Fuzhou, China, and conducted in accordance with the principles of the Declaration of Helsinki and its amendment. All patients provided written informed consent prior to treatment, and all the information was anonymized prior to analysis.
: The manuscript has been approved by all authors for publication.
: The authors declare no competing interests.
